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UBXN1 interacts with the S1 protein 
of transmissible gastroenteritis coronavirus 
and plays a role in viral replication
Peng Yuan†, Shilei Huang†, Zhou Yang, Luyi Xie, Kai Wang, Yang Yang, Lin Ran, Qiuhan Yu and Zhenhui Song*
Abstract 
Transmissible gastroenteritis coronavirus (TGEV) is an enteropathogenic coronavirus that causes diarrhea in pigs and 
is associated with high morbidity and mortality in sucking piglets. S1 is one of two protein domains in the spike (S) 
glycoprotein and is responsible for enteric tropism, sialic acid recognition, and host receptor binding. Although there 
has been extensive research on the S1 protein of TGEV, little is known about the intracellular role of TGEV-S1. In the 
present study, we used yeast two-hybrid screening of a cDNA library from porcine intestinal cells to identify proteins 
that interact with TGEV-S1. Among 120 positive clones from the library, 12 intracellular proteins were identified after 
sequencing and a BLAST search. These intracellular proteins are involved in protein synthesis and degradation, bio-
logical signal transduction, and negative control of signaling pathways. Using a glutathione-S-transferase (GST) pull-
down assay and Co-IP, we found that UBXN1 interacts with the S1 protein. Here, we observed that TGEV infection led 
to increased UBXN1 expression levels during the late phase of infection in IPEC-J2 cells. Inhibition of UBXN1 in IPEC-J2 
cells via siRNA interference significantly decreased the viral titer and downregulated the expression of S1. UBXN1 
overexpression significantly increased the viral copy number. Additionally, we provided data suggesting that UBXN1 
negatively regulates IFN-β expression after TGEV infection. Finally, our research indicated that UBXN1 plays a vital role 
in the process of TGEV infection, making it a candidate target for the development of a novel antiviral method.
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/
publi cdoma in/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Transmissible gastroenteritis virus (TGEV) is a patho-
genic agent of porcine transmissible gastroenteritis 
(TGE), which causes vomiting, diarrhea, and high mor-
tality in suckling piglets, resulting in heavy losses to 
the pig breeding industry [1]. TGEV is an enteropatho-
genic coronavirus (order Nidovirales, family Coronaviri-
dae) with a large, positive-sense, single-stranded RNA 
genome. The genome contains nine open reading frames 
(ORFs) encoding 16 kinds of nonstructural proteins and 
four structural proteins, spike (S), envelope (E), mem-
brane (M), and nucleoprotein (N), which are arranged 
in the order of 5′-replicase-(1a/1b)-S-3a-3b-E-M-N-7-3′ 
[2]. The spike protein is the largest of the four structural 
proteins; as the main envelope glycoprotein on the virion 
surface [3], S plays a key role in the early infection of 
TGEV [4].
The S protein contains an N-terminal globular S1 
domain and a C-terminal S2 region in the form of a stalk 
that connects S1 with the viral envelope [5]. In the early 
stage of TGEV infection, TGEV-S1 is mainly responsible 
for binding to cellular receptors, and the S2 domain is 
associated with membrane fusion between the virus and 
host cells. Compared with the S2 domain, the S1 domain 
has many significant functions similar to those of the 
entire S protein, including enteric tropism [6], sialic acid-
binding activity [7], neutralizing antibody induction, and 
host receptor binding. Determinants for enteric tropism 
and sialic acid recognition are located in a 224 aa region 
at the N terminus of the TGEV S1 domain. In addition, 
the receptor binding domain (RBD) of TGEV, which 
resides in a 150 aa fragment at the C-terminus of the 
S1 region, recognizes and binds to the cellular receptor, 
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porcine aminopeptidase N (pAPN). The four main anti-
genic sites (A to D) on the S protein are mostly contained 
within the S1 domain [8]. Interestingly, the immuno-
genicity of TGEV S1 is stronger than that of the whole 
S protein and is the major inducer of TGEV-neutralizing 
antibodies [9].
The features of TGEV-S1 mentioned above were indi-
cated that it would be important for TGEV invasion 
of host cells. Many studies have examined the roles of 
TGEV-S1 during viral invasion of host cells; however, lit-
tle is known about the intracellular function of TGEV-S1. 
In the present study, using a yeast two-hybrid system, we 
found that TGEV-S1 interacts with multiple intracellular 
proteins, including UBX domain-containing protein 1 
(UBXN1).
UBXN1 is a member of the UBX family that is believed 
to regulate many cellular activities. The UBX family is 
characterized by low homology with ubiquitin at the 
amino acid level but has the same 3-dimensional struc-
ture as ubiquitin [10]. UBXN1 has the same structure as 
NSFL1C, UBXD7, UBXD8, and FAF1. All of these pro-
teins feature an N-terminal UBA domain and a C-ter-
minal UBX domain [11]. The N-terminal UBA domain 
binds and functions as a cofactor for valosin-containing 
protein (VCP), also known as p97, which plays a cen-
tral role in many ubiquitin-mediated pathways and in 
numerous biological activities, including cell cycle and 
protein damage [12]. The C-terminal UBX domain has a 
strong inhibitory effect on the RNA virus-induced type 
I interferon response [13]. In the present study, we fur-
ther confirmed that UBXN1 is associated with TGEV-S1 
expression and TGEV replication, and our findings pro-
vide insight into the role of UBXN1 in TGEV infection.
Materials and methods
Strains, cells, and virus
Y187 yeast cells harboring the IPEC-J2 cDNA library 
and Y2HGold yeast cells harboring the TGEV-S1 gene 
(pGBKT7-S1) were constructed by our group [14]; the 
Y2HGold and Y187 cells were purchased from Clontech, 
Japan. Porcine small intestinal epithelial cells (IPEC-J2) 
and the TGEV Miller strain (TGEV Miller) were stored in 
the laboratory.
Plasmids and antibodies
The prokaryotic expression vectors pGEX-4T-1 and pET-
28a were provided by Jian Wu from the Lanzhou Veteri-
nary Research Institute, (LVRI, Gansu Province, China). 
The anti-C-Myc antibodies, anti-GST-tag antibodies, 
and anti-His-tag antibodies were purchased from San-
gon Biotech, China. Rabbit polyclonal antibodies (pAbs) 
recognizing UBXN1 and horseradish peroxidase (HRP)-
conjugated goat anti-rabbit IgG were purchased from 
Proteintech, USA. Polyclonal antibodies recognizing the 
TGEV S1, and M proteins were donated by Yu Bai from 
the Wenzhou College of Science and Agriculture. Small 
interfering RNA (siRNA) and the Plenti-CMV-GFP-2A-
Puro-UBXN1 overexpression plasmid were constructed 
by Longda Bio, China.
Yeast two‑hybrid system
Y2HGold (pGBKT7-S1) yeast were activated, and the 
baseline expression level of the S1 protein was assessed 
by Western blotting.
Yeast cells harboring the cDNA library were diluted at 
1/10, 1/100, 1/1000, and 1/10 000, and 100 µL was spread 
onto SD/−Leu plates. The number of colonies that grew 
on the plates was counted to determine the library capac-
ity. Twenty-four clones were randomly selected to test 
the quality of the prey library using PCR. The yeast two-
hybrid assay was performed according to the instruc-
tions of the Matchmaker Gold Yeast Two-Hybrid System. 
Y2HGold (pGBKT7-S1) and Y187 (IPEC-J2 cDNA) cells 
were mixed and incubated at 30  °C for 3–5  days. The 
culture mixture was plated on SD/100  µL Trp/−Leu/−
Ade. All white colonies that grew were plated onto 
higher-stringency SD/−Trp/−Leu/−Ade/−His/X-α-Gal 
plates. Finally, all blue colonies that grew on SD/−Trp/−
Leu/−Ade/−His/X-α-Gal/AbA plates were selected and 
inoculated into YPDA liquid medium. The positive prey 
plasmids were rescued, and their cDNA inserts were 
sequenced to identify the candidate proteins.
GST pulldown assay
Under induction by 1  mM isopropyl-b-d-thiogalacto-
pyranoside (IPTG), glutathione-S-transferase (GST)-S1 
was expressed by E. coli strain Rosetta harboring pGEX-
4T-S1, which was constructed using the indicated prim-
ers (Table  1). The porcine UBXN1 gene was amplified 
by PCR using the indicated specific primers (Table  1) 
and cloned into pET-28a to generate pET-28a-UBXN1, 
which expressed His-UBXN1. GST-S1 and His-UBXN1 
were coincubated at 4  °C for 8 h. The mixture was then 
subjected to GST pulldown using GST spin columns. The 
eluted proteins were analyzed via 10% polyacrylamide gel 
electrophoresis (PAGE).
Coimmunoprecipitation (Co‑IP) assay
The lysate of IPEC-J2 cells infected with TGEV Miller 
for 36  h was prepared with RIPA lysis buffer (Protein-
tech) containing the protease inhibitor phenylmethane-
sulfonyl fluoride (PMSF) (1 mM). After centrifugation at 
10 000 ×  g for 20 min and measurement of the protein 
concentration using the BCA method, the lysate super-
natant was pretreated with protein A/G PLUS-Agarose 
(Proteintech) for 60 min at 4 °C to purify the protein. The 
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lysate supernatant (700 μg) was incubated with 3 μg of a 
rabbit pAb against UBXN1 overnight at 4 °C. Next, 10 μL 
of Protein A/G PLUS-Agarose was added to this mixture 
and incubated with shaking at 4  °C for 4 h. After wash-
ing four times with lysis buffer, the eluted proteins were 
analyzed by SDS-PAGE and Western blotting using pAbs 
recognizing the S1 protein of TGEV and rabbit pAbs rec-
ognizing UBXN1. The lysate of IPEC-J2 cells uninfected 
with TGEV was used as the control.
Small interfering RNA (siRNA) assays
siRNA targeting UBXN1, 5′-CCT CAT CGA GAT GGG 
CTT T-3′ (produced by RIBO BIO, China), was trans-
fected into susceptible IPEC-J2 cells, which were cultured 
overnight in six-well plates. Transfection with siRNA was 
performed using Lipofectamine™ 3000 (Thermo Fisher, 
USA) according to the manufacturer’s instructions. The 
transfection complex (8 nM siRNA) was added and incu-
bated for 24 h, followed by removal of the culture super-
natant. The collected samples were analyzed by Western 
blotting using a rabbit pAb recognizing UBXN1 as the 
primary antibody and HRP-conjugated goat anti-rabbit 
IgG as the secondary antibody. The siRNA sequence that 
caused the largest reduction in the expression of UBXN1 
was used in subsequent studies of TGEV infection.
Overexpression of UBXN1
IPEC-J2 cells were cultured overnight in six-well plates 
at 37  °C, and the prepared plasmid Plenti-CMV-GFP-
2A-Puro-UBXN1 (2.67 μg) was then transfected into the 
cells for 36 h. Then, the cells were incubated with TGEV 
Miller (MOI, 0.1) at 37  °C and 5%  CO2. The cells were 
collected after 24  h, and the lysate of IPEC-J2 cells was 
analyzed using absolute quantitative PCR to determine 
the TGEV copy number, as described above.
TCID50 assay
Transmissible gastroenteritis virus-infected cells were 
collected after treatment with the interference fragment 
and overexpression plasmid for 24 h. The viral titers and 
TGEV copy numbers were determined at different time 
points, and the growth kinetics curves were plotted. The 
cells were subjected to three freeze–thaw cycles, diluting 
7 concentrations by tenfold gradient from  10−1 to  10−7, 
and added to 96-well plates. Each dilution was added to 
eight replicate wells. The viral titer was measured in the 
TGEV-infected, virus-infected-interference and virus-
infected-overexpression groups. The method of Reed and 
Muench was then used to calculate the  TCID50 of the 
virus for the different groups.
Real‑time quantitative PCR
At 12 h after incubation with TGEV at a multiplicity of 
infection (MOI) of 0.1 in each well of 6-well plates, total 
RNA was extracted from the cells using RNAiso Plus rea-
gent (Invitrogen, USA) and subsequently reverse tran-
scribed to cDNA (4 ng) using PrimerScript™ RT Master 
Mix (Takara, Japan). The β-actin and UBXN1 genes were 
subjected to quantitative real-time PCR using gene-spe-
cific primers (Table  2). The cycling conditions were as 
Table 1 Primers used to construct the recombinant plasmids 
Gene Accession number Purpose Sequence (5′–3′)
TGEV-S1 DQ811786.2 Construction of pGBKT7-S1 F: CTC TTC CAG CCC TCC TTC C
R: GGT CCT TGC GGA TGTCG 
TGEV-S1-t XM_003353824.1 Construction of pGEX-4T-S1 F: CGG AAT TCG AGA AGG CTC TGG CCC TCA 
R: GGC GCA TTT CGT CTT CCT GG
UBXN1-t DQ811786.2 Construction of pET-28a-UBXN1 F: TCG GTC GAC TCA ACT GGG ACA-CTT CTT 
R: GCG GTC GAC TTA GTT TGT CTA ATA ATA 
Table 2 Primer sequences for real-time quantitative PCR 
Gene Accession number Sequence (5′–3′) Size (bp) Concentration
β-Actin XM_003124280.2 F: CTC TTC CAG CCC TCC TTC C 97 0.5 µM
R: GGT CCT TGC GGA TGTCG 
UBXN1 XM_003353824.1 F: TTG GAG CTT GTG GCC CAG AA 139
R: GGC GCA TTT CGT CTT CCT GG
TGEV-N NC_038861.1 F: TTC AAC CCC ATA ACC CTC CAA CAA 136
R: GGC CCT TCA CCA TGC GAT AGC 
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follows: 95 °C for 30 s, followed by 40 cycles at 95 °C for 
5 s and 55 °C for 30 s. A negative control was included in 
each run, and the specificity of the amplification reaction 
was tested by melting curve (Tm value) analysis. The rel-
ative expression levels of the three genes were compared 
using the  2−∆∆Ct method [15].
Absolute quantification of TGEV by real‑time PCR
To detect viral replication, we constructed a recombinant 
plasmid containing the N gene and used the TGEV-N 
gene to establish a relationship between the copy num-
ber (X) and the Ct (Y) value. Total viral RNA was pre-
pared from the collected cells as described above. The 
primers for TGEV-N (Table  2) were used to quantify 
the TGEV copy number via absolute quantitative PCR 
conducted with Power SYBR Green PCR Master Mix 
(Takara, Dalian, China) according to the manufacturer’s 
instructions. All data were obtained with a mini Q-PCR 
machine and analyzed with GraphPad Prism 6 software 
based on the cycle threshold (∆∆Ct) method.
Western blotting
siRNA targeting UBXN1 was transfected into IPEC-J2 
cells in six-well plates. After 24  h, the cell culture was 
infected with TGEV Miller at a MOI of 0.1 and incubated 
for 24 h. Then, 200  μL of lysis buffer RSVP (containing 
1  mM PMSF) was added into each well. The cells were 
scraped and collected into tubes, and the tubes were 
then incubated on ice for 30 min. The lysis products were 
centrifuged at 10 000 × g and 4 °C for 10 min to prepare 
samples for Western blotting.
Enzyme‑linked immunosorbent assay (ELISA)
IPEC-J2 cells were seeded in six-well plates at a density 
of 1.0 × 105  cells per well. When grown to a confluence 
of approximately 50–60%, the cells were separately trans-
fected with either the overexpression plasmid or siRNA1. 
Cells with siRNA interference were incubated with 
TGEV Miller at an MOI of 0.1 for 24 h. Cells transfected 
with the overexpression plasmid were incubated with 
TGEV Miller for 36 h The lysate supernatant of IPEC-J2 
cells was collected at 1 h, 12 h and 24 h after TGEV infec-
tion. NC was established as the blank control, and cells 
infected with TGEV were used as the infection control. 
Each experiment was performed in triplicate. The col-
lected samples were centrifuged at 1000 × g for 20 min, 
and the supernatants were added to each well of a 96-well 
plate. The wells were coated with 100  µL of conjugate 
reagent at 37 °C for 60 min. Subsequently, each well was 
washed three times with wash buffer. Prior to adding stop 
solution, chromogenic agents A and B were sequentially 
added to each well. The assay was conducted according 
to the manufacturer’s instructions (MEIMIAN, China) 
and analyzed at a wavelength of 450 nm with correction 
at 570 nm.
Statistical analysis
All results in the figures are presented as the 
means ± standard deviations (SDs) of three independent 
experiments, using GraphPad Prism (GraphPad Software 
6, Inc.) For each assay, a t-test was used for statistical 
comparison, and a p value of < 0.05 was considered statis-
tically significant.
Results
Identifying host proteins interacting with TGEV‑S1 
via a two‑hybrid assay
The bait vector pGBKT7 in the yeast two-hybrid system 
was constructed to screen the interactions between the 
TGEV-S1 protein and host proteins, and the recombi-
nant plasmid was successfully transformed into Y2HGold 
yeast cells (Figure  1A). Western blotting showed that 
pGBKT7-S1 produced a fusion protein of approximately 
100  kDa (Figure  1B). Yeast cells harboring pGBKT7-S1 
and those harboring pGBKT7 (control) were spread at 
two dilutions onto SD/Trp plates, and the size and num-
ber of yeast colonies produced by pGBKT7-S1 were com-
pared with those of colonies produced by the control 
pGBKT7. The results suggest that the bait vector was 
not toxicity to the yeast (Figure 1C). Yeast cells harbor-
ing pGBKT7-S1 were spread at two dilutions on plates 
of three different selective media. No colony growth was 
observed on the SD/−Trp/X-α-Gal/AbA plates, indicat-
ing that there was no self-activation phenomenon for the 
reporter genes (Figure  1D). These results indicate that 
the constructed pGBKT7-S1 bait vector could be used 
the yeast two-hybrid system for screening host proteins 
that interact with the TGEV-S1 protein. TGEV-S1 pro-
tein-associated cellular proteins were identified using the 
yeast two-hybrid system. The zygotes typically displayed 
a three-lobed structure similar to a “Mickey Mouse” face 
at 40× magnification (Figure  1E) after the bait strains 
Y2HGold (pGBKT7-S1) and Y187 (pIECs cDNA) were 
mixed and incubated. After three rounds of screening 
on plates with different nutrient-deficient media, a total 
of 120 blue clones that grew on the SD/−Trp/−Leu/−
Ade/−His/X-α-Gal/AbA plates were visible (Figure  1F). 
Finally, twelve candidate proteins were available for a 
BLAST search of the sequencing results (Table 3).
UBXN1 interacts with the TGEV‑S1 protein
Next, the interaction between the S1 protein and can-
didate protein UBXN1 was verified using a GST pull-
down assay and Co-IP. The His-UBXN1 fusion protein 
solution was added to Glutathione™4B agarose beads 
adsorbed with the GST-S1 fusion protein at the same 
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concentration. The GST protein was used as the control 
to eliminate nonspecific protein binding. As shown in 
Figure 2A, the SDS-PAGE and Western blotting results 
revealed that the UBXN1 protein was present in the 
gel from the GST-S1 protein-immobilized beads but 
not in the other gels, and the Western blot indicated 
that the size of the His-UBXN1 fusion protein was 
approximately 42  kDa (Figure  2B). A Co-IP assay was 
performed to further verify the interaction between 
UBXN1 and TGEV-S1 in vitro. The Western blot (right) 
shown in Figure  2C indicates that the S1 protein was 
precipitated by the antibody in the TGEV-infected 
group but not in the mock-treated group. These results 
confirm the interaction between UBXN1 and the S1 
protein both in vitro and in vivo.
Figure 1 Testing bait protein expression, autoactivation, and toxicity. A Yeast colony identification by PCR. M: DNA marker DL5000; 1–2: PCR 
of colonies transformed with pGBKT7-S1; −: blank control. B Expression of S1 in yeast by Western blotting. 1: pGBKT7 negative control; 2: pGBKT7-53 
positive control; 3: pGBKT7-S1 expressed protein. C Toxicity assessment of the pGBKT7-S1 bait plasmid. Yeast cells harboring pGBKT7-S1 and the 
pGBKT7 control plasmid were spread at two dilutions (1:10 and 1:100) on SD/Trp plates, and the size and number of the colonies were compared 
to evaluate the toxicity of the bait plasmid. D Identification of autoactivation of the pGBKT7-S1 bait plasmid. Yeast cells harboring pGBKT7-S1 were 
spread at 1/10 and 1/100 dilutions on SD/−Trp, SD/−Trp/X-α-Gal, and SD/−Trp/X-α-Gal/AbA plates for autoactivation testing. E A yeast two-hybrid 
system was used to screen for S1-interacting proteins. Diploids after yeast two-hybrid screening. The zygotes typically displayed a three-lobed 
structure similar to a “Mickey Mouse” face at 40× magnification. F The third screen was conducted using SD/−Trp/−Leu/−Ade/−His/X-α-Gal/AbA 
selective medium.
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TGEV infection leads to increased UBXN1 expression levels
We confirmed that there was indeed an interaction 
between TGEV-S1 and UBXN1 by GST pulldown and 
Co-IP assays in  vitro and in  vivo. However, it was not 
clear whether this interaction was involved in the infec-
tion or replication of TGEV. Therefore, we infected 
IPEC-J2 cells with TGEV at an MOI of 0.1 and observed 
the changes in the UBXN1 mRNA and protein levels. 
The results showed that the UBXN1 mRNA and protein 
levels were significantly increased in IPEC-J2 cells after 
TGEV infection for 24 h (Figure 3).
UBXN1‑mediated infection and replication of TGEV
We determined that TGEV infection caused the upreg-
ulation of UBXN1 expression. We hypothesized that 
UBXN1 might mediate the infection and replication 
of TGEV, thus controlling the expression of UBXN1, 
which might cause corresponding changes in TGEV. 
The final result confirmed our hypothesis. We intro-
duced interference and overexpression (Figures 4A and 
B) techniques to inhibit and overexpress UBXN1, and 
Figure  4C shows that the transfection reagents and 
overexpression reagents that we used were not toxic to 
the cells.
We generated the viral growth curves of TGEV 
under normal, interference and overexpression con-
ditions (Figures  5A  and B). We first observed changes 
in the titer of TGEV. After siRNA interference and 
overexpression for 24  h, IPEC-J2 cells were infected 
with TGEV for 12  h, and the replication of TGEV 
was investigated by a  TCID50 assay. The result shows 
that the  TCID50 in the siRNA group  (TCID50 = 102.9/
mL) was lower than that in the virus-infected group 
 (TCID50 = 104.3/mL). The  TCID50 in the overexpression 
group  (TCID50 = 105.4/mL) was higher than that in the 
virus-infected group  (TCID50 = 104.3/mL) (Figure 5A).
To further verify our hypothesis, we then detected 
the levels of TGEV mRNA and protein under the con-
ditions of UBXN1 gene silencing and overexpression.
The harvested cells were examined by absolute quan-
titative PCR. The equation for the standard curve based 
on the N gene as the target gene for measuring the viral 
copy number was y = − 3.602 × X + 40.5. The expres-
sion level of TGEV-N declined when the expression of 
UBXN1 was inhibited, and the viral copy number was 
1.84 × 103  copies/mL, lower than that in the TGEV-
infected group; the TGEV copy number in the overex-
pression group was 7.32 × 105  copies/mL, higher than 
that in the TGEV-infected group (Figure  5C). In addi-
tion, the mRNA level of UBXN1 also showed the same 
trend as the copy number of TGEV (Figure 5D).
Considering that the expression of UBXN1 was 
upregulated by TGEV infection, we mainly explored 
the changes in TGEV at the protein level by inhibiting 
UBXN1 expression via siRNA interference (Figure 5E). 
Protein samples were collected from the virus-infected 
group and the virus-infected siRNA interference group 
and examined by Western blotting. The results showed 
that the S1 and M protein levels in the virus-infected 
siRNA interference group were lower than those in the 
virus-infected group (Figures 5F and G).
The final results showed that UBXN1 interference 
and overexpression could decrease and increase the 
replication of TGEV, respectively. There was a posi-
tive correlation between UBXN1 expression and TGEV 
replication in IPEC-J2 cells. The viral titer, viral copy 
number and protein levels of S1 and M all showed to be 
associated with UBXN1 expression.
Table 3 BLAST search results for the positive clones 
Among these positive clones, the sequences of eight clones produced no BLAST results, and 12 different BLAST results were obtained from the remaining clones.
Number of repeats Protein name NCBI accession no.
22 UBX domain-containing protein 1 XM_003353824.1
12 Kinesin-like protein KIF2C XP_014384723.1
4 Calcium-binding protein 2-like XP_019950966.1
2 DUF1410 domain-containing protein WP_069096724.1
4 Bifunctional glutamate–proline—tRNA ligase AAH88324.1
22 Asparaginyl-tRNA synthetase (NARS2) AAH30041.1
8 Microsomal glutathione S-transferase 1 NP_999465.1
4 Glutaminyl-tRNA synthetase (GlnRS) AAU85385.1
2 Tau-DTfdA family dioxygenase WP_034307978.1
8 Bifunctional aminoacyl-tRNA synthetase EGV92541.1
22 Asparagine—tRNA ligase XP_021085155.1
2 Sensor histidine kinase WP_018684459.1
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UBXN1 negatively regulates IFN‑β production induced 
by TGEV infection
It is well known that TGEV infection can induce cells to 
produce a large amount of interferons, and UBXN1 has 
a negative regulatory effect on the expression of type I 
interferon. Previously, we indicated that the expression of 
UBXN1 is upregulated by TGEV infection. Therefore, we 
hypothesized that TGEV may inhibit interferon expres-
sion by upregulating UBXN1 expression. We measured 
the expression of IFN-β after siRNA interference with 
and overexpression of UBXN1 without TGEV infec-
tion. The results confirmed that neither interfering with 
nor overexpressing UBXN1 caused a change in IFN-β 
expression without induction by TGEV. However, in the 
setting of TGEV infection, interference with and over-
expression of UBXN1 greatly changed the expression 
of IFN-β. Overexpression of UBXN1 decreased IFN-β 
expression (Figure  6A), while interference with UBXN1 
expression increased IFN-β expression (Figure 6B).
Discussion
In the present study, most of the 20 proteins identified 
to interact with TGEV-S1 are involved in the synthesis 
and transport of proteins, biological signal transduc-
tion, and negative regulation of signal pathways. Five of 
the screened proteins were aminoacyl-tRNA synthetases 
Figure 2 SDS‑PAGE (A) and Western blotting (B) results of the glutathione‑S‑transferase (GST) pulldown assay and CO‑IP assay. The 
GST-S1 and His-UBXN1 fusion proteins were used in the GST pulldown assay to verify the interaction between S1 and UBXN1. Lanes 1 and 4: result 
of S1 and UBXN1 pulldown; lanes 2 and 5: His-UBXN1 fusion protein (42 kDa); lanes 3 and 6: GST-S1 fusion protein (97 kDa) and GST tag blank 
control (20 kDa). C Co-IP assay for the interaction between S1 and UBXN1 in vivo. IPEC-J2 cells were infected with TGEV Miller for 36 h and were then 
subjected to a Co-IP assay. The coimmunoprecipitated proteins were detected by SDS-PAGE (left) and Western blotting (right). +: virus-infected 
group; −: normal group.
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(ARSs). ARSs are widely expressed among organisms and 
are responsible for catalyzing the attachment of amino 
acids to their cognate tRNAs [16], and the role of ami-
noacyl-tRNA synthetases in TGEV infection has already 
been explored [17]. Microsomal glutathione transferase 
1 (MGST1) is a membrane-associated protein in the 
eicosanoid and glutathione metabolism (MAPEG) super-
family, which are glutathione-S-transferases (GSTs) [18]. 
MGST1 is widely distributed, with high levels in the 
endoplasmic reticulum (ER) and outer mitochondrial 
membrane (OMM). MGST1 is an ER-membrane-bound 
enzyme [19, 20]. MGST1 participates in a variety of 
physiological activities, including cellular defense against 
toxic, carcinogenic, and pharmacologically active elec-
trophilic compounds (thereby protecting cells against 
 H2O2-induced cell trauma) [2, 21]. The sensor histidine 
kinase is a membrane receptor with the highest diver-
sity among all biological activities of microorganisms 
[22]. The receptor region of this protein is responsible for 
structural dynamics in control signal regulation [23]. This 
receptor functions in two-component signaling systems 
(TCSs); tens of thousands of TCSs are necessary for many 
aspects of biological activities in cells, including growth 
and survival [24]. Kinesin-like protein (KIF2C) belongs to 
the kinesin superfamily proteins (KIFs) and has the fea-
tures of a highly conserved structural domain and a core 
that catalyzes hydrolysis. KIF2C plays a significant role in 
intracellular transport systems as a molecular motor that 
transmits the energy released from chemical reactions 
into mechanical motion [25]. Calcium-binding protein 
2-like regulates its own biological activities via a revers-
ible interaction of its specific protein-binding sites with 
 Ca2+ [26].  Ca2+ is a common intracellular signal carrier 
that regulates many cellular processes from cell birth, dif-
ferentiation, and reproduction to apoptosis [27].
In our screening results, UBXN1 appeared at a high fre-
quency among the candidate proteins and was known to 
have a strong inhibitory effect on the RNA virus-induced 
type I interferon response [13]. Therefore, the candi-
date protein UBXN1 was selected as protein of interest 
for further verification of its interaction with TGEV-S1. 
Recently, UBXN1 was identified as a negative regulator 
in the tumor necrosis factor alpha (TNF-α)-mediated 
signaling pathway [11]. In the process of TGEV infection 
of IPEC-J2 host cells, the RNA of the single-stranded, 
positive-sense RNA virus TGEV is recognized as a viral 
pathogen-associated molecular pattern (PAMP). PAMPs 
are mainly regulated by cytoplasmic receptors, such as 
RIG-I-like receptors (RLRs) and melanoma differentia-
tion-associated protein 5 (MDA5) [28]. Once the viral 
RNA is recognized, RIG-1 and MDA5 trigger a signal 
cascade reaction, stimulating the production of cytokines 
Figure 3 TGEV infection led to increased UBXN1 expression levels. Cell and protein samples from the group infected with TGEV for 24 h and 
the blank control group were collected, and the mRNA and protein levels of UBXN1 were determined. A Relative mRNA levels of UBXN1. B Relative 
protein expression of UBXN1. Control: blank group; TGEV: TGEV-infected group.
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and chemokines. Type I interferons (IFNs) are quickly 
produced to establish the antiviral status in host cells. 
Mitochondrial antiviral-signaling protein (MAVS) (also 
known as IPS-1, CARDIF, and VISA) is an important 
protein in the RLR signaling pathway. MAVS binds to 
viruses via an interaction between the N-terminal cas-
pase recruitment domain (CARD) of RLRs. Then, the 
TRAF functional module (TIM) recruits the E2 ligases 
TRAF3 and TRAF6, which activate canonical IκB kinases 
(IKKs) and IKK-related kinases such as TBK1 and IKKε, 
and eventually promoted the production of type I IFNs 
and proinflammatory factors [29].
Mitochondrial antiviral-signaling protein, as a cen-
tral adaptor of RLRs, is negatively regulated by UBXN1. 
After infection with TGEV, UBXN1 is induced to recruit 
MAVS. UBXN1 blocks the binding site of TRAF3/6 (aa 
450–480), which is important for MAVS-mediated regu-
lation of the IFN induction. The binding of UBXN1 to 
MAVS interferes with intracellular MAVS oligomeriza-
tion and blocks the formation of the MAVS/TRAF3/
TRAF6 signalosome to inhibit the type I IFN response 
[2]. It has been confirmed that the N terminus of UBXN1 
is responsible for binding to MAVS (aa 438–467) and that 
UBXN1’s functions in ubiquitination are independent of 
binding to VCP/p97 [30].
We confirmed the interaction between TGEV-
S1 and UBXN1 using yeast two-hybrid screening, 
which suggested that TGEV-S1 might participate in 
Figure 4 Interference and overexpression of UBXN1. A, B siRNA interference fragments reduced the expression of UBXN1. The relative 
expression of UBXN1 was assessed by Western blotting after 24 h of interference. Control: normal group; NC1: transfection reagent group; siRNA: 
fragment 1. B The lentiviral plasmid overexpressed UBXN1. The plasmid was transfected into cells for 36 h, and the relative expression of UBXN1 was 
assessed by Western blotting. Control: normal group; NC2: transfection reagent group; Overexpression: transfection plasmid group. C Molecular 
modulators of UBXN1 do not affect cell viability. Cell viability was determined by an MTT assay after treatment with the interference fragment 
(SiRNA) or overexpression plasmid (Plenti-CMV-GFP-2A-Puro-UBXN1) for 48 h. The data are the means ± SEMs of three independent experiments 
(t-test, #p > 0.05). Control: normal group; IF1: interference fragment 1 group; TP: transfection plasmid group.
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Figure 5 UBXN1 mediated the infection and replication of TGEV. A, B Generation of the viral proliferation curves in IPEC-J2 cells under different 
conditions. The cells were transfected with siRNA interference fragments and overexpression plasmids for 24 h and were then infected with virus 
to measure the  TCID50 and copy numbers. C, D Quantitative real-time reverse transcription PCR results. At 12 h after the cells were incubated with 
TGEV Miller, qRT-PCR was performed to measure the mRNA expression levels of TGEV N, UBXN1 and β-actin. The standard curve based on N was 
used to examine the TGEV copy number. TGEV-infection: virus-infected group; siRNA: virus-infected siRNA interference group. Overexpression: 
virus-infected overexpression group. NC: blank group. E–G Western blotting results after siRNA interference and viral infection. At 24 h after siRNA 
interference, the cells were incubated with TGEV Miller. After 48 h, the cells were harvested and assessed by Western blotting for UBXN1, S1, and M 
protein expression. TGEV: virus-infected group; siRNA TGEV: virus-infected siRNA interference group.
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UBXN1-related intracellular biological functions. 
UBXN1 directly bound to S1 in  vitro and in  vivo, as 
determined by the GST pulldown and Co-IP assays. 
Moreover, we found that TGEV-S1 and UBXN1 had 
a positive association. TGEV infection triggered an 
increase in the UBXN1 levels, and UBXN1 promoted 
TGEV proliferation, as proven by the siRNA and over-
expression assays. We deduced that the binding of 
TGEV-S1 to UBXN1 induced UBXN1 expression to 
enhance TGEV proliferation. TGEV infection induces 
massive production of IFN-I in host cells, but it also 
results in a variety of immune escape mechanisms with 
IFN resistance. Finally, we confirmed by siRNA and 
overexpression assays that UBXN1 had a negative rela-
tionship with IFN-β, suggesting that TGEV infection 
promoted UBXN1 to inhibit the production of IFN-β in 
the late stage of infection to augment proliferation. The 
detailed mechanism of this process is worthy of further 
research.
In the present study, we identified 12 candidate pro-
teins that potentially interact with TGEV-S1 in porcine 
small intestinal epithelial cells. Most of these proteins 
are involved in protein synthesis and transport, bio-
logical signal transduction, and negative regulation of 
signaling pathways; therefore, it is likely that TGEV-
S1 has multiple functions in intracellular protein-
related processes. We further confirmed the interaction 
between TGEV-S1 and UBXN1 and found that UBXN1 
expression increased after TGEV infection. Moreover, 
UBXN1 negatively regulated TGEV-induced IFN pro-
duction. We reported for the first time the interaction 
between TGEV-S1 and the UBXN1 protein in IPEC-J2 
cells and found that UBXN1 plays an important role 
in the replication of TGEV in cells. In summary, the 
UBXN1-S1 complex may have a regulatory effect on 
TGEV infection-induced IFN production. These find-
ings will lay a foundation for further understanding 
TGEV pathogenesis.
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